Bank of New York Mellon Corp raised its position in shares of MedEquities Realty Trust Inc. (NYSE:MRT) by 51.2% in the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 107,443 shares of the financial services provider’s stock after purchasing an additional 36,394 shares during the quarter. Bank of New York Mellon Corp owned 0.34% of MedEquities Realty Trust worth $1,356,000 at the end of the most recent quarter.
A number of other large investors have also recently added to or reduced their stakes in MRT. UBS Group AG increased its stake in MedEquities Realty Trust by 190.0% during the 1st quarter. UBS Group AG now owns 13,504 shares of the financial services provider’s stock valued at $151,000 after purchasing an additional 8,847 shares in the last quarter. Eqis Capital Management Inc. bought a new stake in MedEquities Realty Trust during the 2nd quarter valued at about $153,000. Acadian Asset Management LLC bought a new stake in MedEquities Realty Trust during the 2nd quarter valued at about $175,000. Teachers Advisors LLC bought a new stake in MedEquities Realty Trust during the 4th quarter valued at about $257,000. Finally, Skandinaviska Enskilda Banken AB publ bought a new stake in MedEquities Realty Trust during the 1st quarter valued at about $293,000. Institutional investors and hedge funds own 92.83% of the company’s stock.
Shares of MedEquities Realty Trust Inc. (MRT) opened at 11.65 on Friday. The stock has a market cap of $369.95 million and a P/E ratio of 35.41. The stock’s 50 day moving average is $11.67 and its 200-day moving average is $11.90. MedEquities Realty Trust Inc. has a one year low of $10.28 and a one year high of $13.06.
A number of analysts have weighed in on MRT shares. Zacks Investment Research upgraded shares of MedEquities Realty Trust from a “sell” rating to a “hold” rating in a research note on Wednesday, July 19th. Cantor Fitzgerald started coverage on shares of MedEquities Realty Trust in a research note on Thursday, August 31st. They set an “overweight” rating and a $14.00 price objective for the company. Finally, KeyCorp restated a “buy” rating and set a $13.00 price objective on shares of MedEquities Realty Trust in a research note on Friday, August 25th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and six have issued a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average target price of $13.00.
MedEquities Realty Trust Company Profile
MedEquities Realty Trust, Inc is a real estate investment trust (REIT). The Company invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company invests primarily in real estate across the acute and post-acute spectrum of care. It focuses on investing in various types of healthcare properties, including acute care hospitals; skilled nursing facilities; short-stay surgical and specialty hospitals, which focus on orthopedic, heart and other dedicated surgeries and specialty procedures; dedicated specialty hospitals, such as inpatient rehabilitation facilities, long-term acute care hospitals and facilities providing psychiatric care; physician clinics; diagnostic facilities; outpatient surgery centers, and facilities that support these services, such as medical office buildings.
Receive News & Ratings for MedEquities Realty Trust Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust Inc. and related companies with MarketBeat.com's FREE daily email newsletter.